Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Ferriprox in Iron Overload with SCD/Anemias
NCT02443545Phase 4Terminated
- Sponsor
- ApoPharma Inc.
- Start
- May 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of deferiprone in iron overload, sponsored by ApoPharma Inc.. Started May 2015; status: terminated.
02
Drugs
deferiprone
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT02443545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443545.